The aim of this work was to report on 7 patients presenting a distinctive form of multimodal (tactile and visual) hallucinations for which the term “string hallucinations” is proposed. Having observed a patient interacting with imaginary strips of skin in his hands at our movement disorders unit, we prospectively studied PD patients and caregivers over…
hallucinations
Minor hallucinations occur in drug-naive Parkinson’s disease patients, even from the premotor phase
Objectives The description of minor hallucinatory phenomena (presence, passage hallucinations) has widened the spectrum of psychosis in Parkinson’s disease (PD). Minor hallucinatory phenomena seem to antedate the development of more severe hallucinations. Early detection of minor hallucinations may be useful for screening patients with more severe endophenotypes. Motivated by the observation of “de novo,” drug-naive…
I finally see what you see: Parkinson’s disease visual hallucinations captured with functional neuroimaging
Background Functional neuroimaging studies have described alterations in neural activation in PD patients with chronic hallucinations. These studies have not, however, captured neural activation patterns during an actual hallucinatory event. The objective of this work was to investigate neuroanatomical substrates active during visual hallucinations in a patient with Parkinson’s disease (PD). Methods We conducted an…
Risk factors for hallucinations in Parkinson’s disease: Results from a large prospective cohort study
The aim of this study was to identify risk factors for the development of hallucinations in patients with Parkinson’s disease (PD). A broad range of motor and nonmotor features was assessed at baseline and during the following 5 years in 386 PD patients. Cross-sectional analyses of baseline data and longitudinal analyses of follow-up data were…
REM behavior disorder, hallucinations and cognitive impairment in Parkinson’s disease: A two-year follow up
In Parkinson’s disease (PD) the presence of REM parasonnias as REM Behaviour Disorder (RBD) or vivid dreams/nightmares, is recognized as largely associated with hallucinations, even if the risk of the development of hallucinations seem not to depend on how long the REM parasomnias had been occurring. The aim of this study was to establish if…
A neuropsychological longitudinal study in Parkinson’s patients with and without hallucinations
The aim of this work was to determine the progression of cognitive impairment in Parkinson’s disease (PD) patients with or without hallucinations. Two years after the first assessment, 36 PD patients were re-evaluated on standardized neuropsychological tests, including the Frontal Assessment Battery (FAB), and on rating scales for overall cognitive functioning, functional autonomy, behavioral disorders.…
The changing face of Parkinson’s disease-associated psychosis: A cross-sectional study based on the new NINDS-NIMH criteria
New criteria for Parkinson’s disease-associated psychosis (PDAP) were recently proposed by a NINDS-NIMH working group. We assessed 116 consecutive unselected outpatients with PD for the existence of psychotic symptoms during the previous month, using a structured questionnaire covering the whole spectrum of PDAP symptoms. Hallucinations occurred in 42% of the patients (visual: 16%; nonvisual: 35%),…
Visual plus nonvisual hallucinations in Parkinson’s disease: Development and evolution over 10 years
The objective of the study was to assess the development and evolution of visual and nonvisual hallucinations in patients with Parkinson’s disease over 10 years. Hallucinations increase over time, but minimal attention has been placed on nonvisual domains. We studied 60 patients with Parkinson’s disease who had never hallucinated at baseline and followed them over…
